BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 25708115)

  • 21. Novel head and neck cancer survival analysis approach: random survival forests versus Cox proportional hazards regression.
    Datema FR; Moya A; Krause P; Bäck T; Willmes L; Langeveld T; Baatenburg de Jong RJ; Blom HM
    Head Neck; 2012 Jan; 34(1):50-8. PubMed ID: 21322080
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of the Prognostic Utility of the Diverse Molecular Data among lncRNA, DNA Methylation, microRNA, and mRNA across Five Human Cancers.
    Xu L; Fengji L; Changning L; Liangcai Z; Yinghui L; Yu L; Shanguang C; Jianghui X
    PLoS One; 2015; 10(11):e0142433. PubMed ID: 26606135
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Integration of pathway structure information into a reweighted partial Cox regression approach for survival analysis on high-dimensional gene expression data.
    Liu W; Wang Q; Zhao J; Zhang C; Liu Y; Zhang J; Bai X; Li X; Feng H; Liao M; Wang W; Li C
    Mol Biosyst; 2015 Jul; 11(7):1876-86. PubMed ID: 25891149
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fast calculation of pairwise mutual information for gene regulatory network reconstruction.
    Qiu P; Gentles AJ; Plevritis SK
    Comput Methods Programs Biomed; 2009 May; 94(2):177-80. PubMed ID: 19167129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dimensional Cox models: the choice of penalty as part of the model building process.
    Benner A; Zucknick M; Hielscher T; Ittrich C; Mansmann U
    Biom J; 2010 Feb; 52(1):50-69. PubMed ID: 20166132
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gene association networks from microarray data using a regularized estimation of partial correlation based on PLS regression.
    Tenenhaus A; Guillemot V; Gidrol X; Frouin V
    IEEE/ACM Trans Comput Biol Bioinform; 2010; 7(2):251-62. PubMed ID: 20431145
    [TBL] [Abstract][Full Text] [Related]  

  • 27. System-scale network modeling of cancer using EPoC.
    Abenius T; Jörnsten R; Kling T; Schmidt L; Sánchez J; Nelander S
    Adv Exp Med Biol; 2012; 736():617-43. PubMed ID: 22161356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Network-Regularized Sparse Logistic Regression Models for Clinical Risk Prediction and Biomarker Discovery.
    Min W; Liu J; Zhang S
    IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(3):944-953. PubMed ID: 28113328
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cox-nnet: An artificial neural network method for prognosis prediction of high-throughput omics data.
    Ching T; Zhu X; Garmire LX
    PLoS Comput Biol; 2018 Apr; 14(4):e1006076. PubMed ID: 29634719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene expression complex networks: synthesis, identification, and analysis.
    Lopes FM; Cesar RM; Costa Lda F
    J Comput Biol; 2011 Oct; 18(10):1353-67. PubMed ID: 21548810
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ICan: an integrated co-alteration network to identify ovarian cancer-related genes.
    Zhou Y; Liu Y; Li K; Zhang R; Qiu F; Zhao N; Xu Y
    PLoS One; 2015; 10(3):e0116095. PubMed ID: 25803614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pericytes Promote Malignant Ovarian Cancer Progression in Mice and Predict Poor Prognosis in Serous Ovarian Cancer Patients.
    Sinha D; Chong L; George J; Schlüter H; Mönchgesang S; Mills S; Li J; Parish C; Bowtell D; Kaur P;
    Clin Cancer Res; 2016 Apr; 22(7):1813-24. PubMed ID: 26589433
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inferring cellular regulatory networks with Bayesian model averaging for linear regression (BMALR).
    Huang X; Zi Z
    Mol Biosyst; 2014 Aug; 10(8):2023-30. PubMed ID: 24899235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new multiple regression approach for the construction of genetic regulatory networks.
    Zhang SQ; Ching WK; Tsing NK; Leung HY; Guo D
    Artif Intell Med; 2010; 48(2-3):153-60. PubMed ID: 19963359
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene expression: protein interaction systems network modeling identifies transformation-associated molecules and pathways in ovarian cancer.
    Bapat SA; Krishnan A; Ghanate AD; Kusumbe AP; Kalra RS
    Cancer Res; 2010 Jun; 70(12):4809-19. PubMed ID: 20530682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cancer survival classification using integrated data sets and intermediate information.
    Kim S; Park T; Kon M
    Artif Intell Med; 2014 Sep; 62(1):23-31. PubMed ID: 24997860
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Integrative regression network for genomic association study.
    Vangimalla RR; Jeong HH; Sohn KA
    BMC Med Genomics; 2016 Aug; 9 Suppl 1(Suppl 1):31. PubMed ID: 27535739
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Data Imputation in Epistatic MAPs by Network-Guided Matrix Completion.
    Žitnik M; Zupan B
    J Comput Biol; 2015 Jun; 22(6):595-608. PubMed ID: 25658751
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CN: a consensus algorithm for inferring gene regulatory networks using the SORDER algorithm and conditional mutual information test.
    Aghdam R; Ganjali M; Zhang X; Eslahchi C
    Mol Biosyst; 2015 Mar; 11(3):942-9. PubMed ID: 25607659
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Somatic hypermutation and outcomes of platinum based chemotherapy in patients with high grade serous ovarian cancer.
    Sohn I; Jung WY; Sung CO
    Gynecol Oncol; 2012 Jul; 126(1):103-8. PubMed ID: 22484402
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.